SAMYANG BIOPHARMACEUTICALS CORPORATION – Trademark Portfolio
Entity Type: 03
SAMYANG BIOPHARMACEUTICALS CORPORATION holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include BIOMESH, CROQUIS, GENEXOL, TRISORB, and MONOFAST. The owner is based in SEOUL.
31, Jong-ro 33-gil, Jongno-gu,
SEOUL 03129 , KR
Showing of trademarks Trademarks
Trademark Classifications
SAMYANG BIOPHARMACEUTICALS CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SAMYANG BIOPHARMACEUTICALS CORPORATION have?
SAMYANG BIOPHARMACEUTICALS CORPORATION has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does SAMYANG BIOPHARMACEUTICALS CORPORATION file in?
SAMYANG BIOPHARMACEUTICALS CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are SAMYANG BIOPHARMACEUTICALS CORPORATION's most well-known trademarks?
SAMYANG BIOPHARMACEUTICALS CORPORATION's registered trademark portfolio includes well-known marks such as BIOMESH, CROQUIS, GENEXOL, TRISORB, and MONOFAST. These are among 6 currently registered trademarks in the portfolio.
What is SAMYANG BIOPHARMACEUTICALS CORPORATION's trademark registration success rate?
SAMYANG BIOPHARMACEUTICALS CORPORATION has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.